European Journal of Internal Medicine
Volume 19, Issue 7 , Pages 473-475 , November 2008

Thrombolysis in cardiac arrest: One size fits all or tailored to highly selected patients?

  • Peter Vanbrabant

      Affiliations

    • Department of General Internal Medicine, University Hospitals Leuven Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 16 34 42 75; fax: +32 16 34 42 30.
    • ,
  • Peter R. Sinnaeve

      Affiliations

    • Department of Cardiology, University Hospitals Leuven Campus Gasthuisberg, Leuven, Belgium

Received 9 March 2008 ,Accepted 11 March 2008.

References 

  1. Stiel IA, Wells GA, Field B, Spaite DW, Nesbitt LP, De Maio VJ, et al. Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med. 2004;351:647–656
  2. The hypothermia after cardiac arrest study group . Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl Med. 2002;346:546–549
  3. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557–563
  4. Bunch TJ, White RD, Gersh BJ, Meverden RA, Hodge DO, Ballman KV, et al. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med. 2003;348:2626–2633
  5. Sandroni C, Nolan J, Cavallaro F, Antonelli M. In-hospital cardiac arrest: incidence, prognosis and possible measures to improve survival. Intensive Care Med. 2007;33:237–245
  6. Bozeman WP, Kleiner DM, Ferguson KL. Empiric tenecteplase is associated with increased return of spontaneous circulation and short term survival in cardiac arrest patients unresponsive to standard interventions. Resuscitation. 2006;69:399–406
  7. Fischer M, Böttiger BW, Popov-Cenic S, Hossman KA. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med. 1996;22:1214–1223
  8. Schreiber W, Gabriel D, Sterz F, Muellner M, Kuerkciyan I, Holzer M, et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation. 2002;52:63–69
  9. Böttiger BW, Böhrer H, Bach A, Motsch J, Martin E. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation. 1994;28:45–54
  10. Goldhaber SZ, Nadel ES, King ME, Sharma A. Case 17-2004: a 42-year-old woman with cardiac arrest several weeks after an ankle fracture. N Engl J Med. 2004;250:2281–2290
  11. Ruiz-Bailén M, Ramos-Cuadra JA, Aguayo de Hoyos E. Thrombolysis during cardiopulmonary resuscitation in fulminant pulmonary embolism: a review. Crit Care Med. 2001;29:2211–2219
  12. Arntz H-R, Wenzel V, Dissman R, Marschalk A, Breckwoldt J, Müller D. Out-of-hospital thrombolysis during cardiopulmonary resuscitation in patients with high likelihood of ST-elevation myocardial infarction. Resuscitation. 2008;76:180–184
  13. Duchateau F-X, Preis V, Ricard-Hibon A, Chollet C, Marty J. Out of hospital thrombolytic therapy during cardiopulmonary resuscitation in refractory cardiac arrest due to acute myocardial infarction. Eur J Emerg Med. 2001;8:241–243
  14. Ruiz-Bailén M, Aguayo de Hoyos E, Serrano-Corcoles MC, Diaz-Castellanos MA, Ramos-Cuadra JA, Reina-Toral A. Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care Med. 2001;27:1050–1057
  15. Böttiger BW, Bode C, Kern S, Gries A, Gust R, Glätzer R, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet. 2001;357:1583–1585
  16. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation. 2001;50:71–76
  17. Abu-Laban RB, Christenson JM, Innes GD, van Beek CA, wanger KP, McKnight RD, et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med. 2002;246:1522–1528
  18. Fatovich DM, Dobb GJ, Clugston RA. A pilot randomised trial of thrombolysis in cardiac arrest (the TICA trial). Resuscitation. 2004;61:309–313
  19. Spöhr F, Arntz HR, Bluhmki E, Bode C, Carli P, Chamberlain D, et al. International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) study. Eur J Clin Inves. 2005;3:315–323
  20. Spöhr F, Böttiger WB. Safety of thrombolysis during cardiopulmonary resuscitation. Drug Safety. 2003;26:367–379
  21. Silfvast T. Cause of death in unsuccessful prehospital resuscitation. J Inter Med. 1991;229:331–335
  22. Kuisma M, Alaspaa A. Out-of-hospital cardiac arrests of non-cardiac origin. Epidemiology and outcome. European Heart J. 1997;18:1122–1128
  23. Vanbrabant P, Dhondt E, Billen P, Sabbe M. Aetiology of unsuccessful prehospital witnessed cardiac arrest of unclear origin. Eur J Emerg Med. 2006;13:144–147
  24. 2005 International Consensus on CPR and ECC Science with treatment recommendations . Part 4: advanced Life Support. Circulation. 2005;112(Suppl I):III-25-III54
  25. Nolan JP, Deakin CD, Soar J, Böttiger BW, Smith G. European Resuscitation Council Guidelines for Resuscitation 2005. Section 4. Adult advanced life support. Resuscitation. 2005;67(Suppl 1):S39–S86
  26. Flores J, Garcia de Tena J, de Pablo R, Daguerre M. Successful outcome of cardiopulmonary arrest with systemic thrombolysis. Eur J Int Med. 2008;19:e38–e39

PII: S0953-6205(08)00101-5

doi: 10.1016/j.ejim.2008.03.016

European Journal of Internal Medicine
Volume 19, Issue 7 , Pages 473-475 , November 2008

Article Tools